瑞聲及高偉曾挫逾6%-10% 舜宇跌幅擴大曾瀉15%
藍籌舜宇光學(02382.HK)發盈警料中績少賺逾65%,美銀、花旗及中金隨即下調舜宇目標價至分別為57元、80元及81.9元。該股今天跌破10天及20天線後,沽盤進一步湧現,最多急瀉15%至66.3元(接近去年11月初所創52周低位65元)才喘定,現報68元,逆市急挫13%,成交急增至1,950萬股,已創逾半年高,涉資13.35億元。
其餘手機設備股亦偏軟,高偉電子(01415.HK)股價跌破250天線(14.78元),最多挫逾10%至13.56元,現報13.86元,續挫8.5%,成交增至674萬股。瑞聲(02018.HK)股價也失守10天及20天線,最多跌6.3%低見17.54元,現報17.86元,回吐4.6%,成交增至673萬股。中興(00763.HK)三連跌,最低見29.05元,現報29.25元,續跌3.1%。富智康(02038.HK)跌2.4%報0.82元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.